Suggest anyone interested views the investor presentation released today. It explains a lot including the competition.
One aspect that I like the potential of is in relation to not only diagnosis of ADHD but how the app can assist with defining the effectivity of the medication in a clinical way "Treatment Response Monitoring" rather than just guessing. How many young ones these days are being miss diagnosed with ADHD or correctly diagnosed and then being put on a regime of medication of various dosages based on what exactly? To my knowledge and personal experience, there is no clinical way to determine the correct medication or dosage. It is just trial and error, what feels right and these drugs are just nasty.
The float, page-54
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BB1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $15.69M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 28.5¢ | 27.5¢ | $17.67K | 63.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42703 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 74725 | 1 |
View Market Depth
| Last trade - 14.47pm 04/10/2024 (20 minute delay) ? |
| BB1 (ASX) Chart |